An improved method for the detection of soluble interleukin 2 receptors in liver transplant recipients by flow cytometry.
A new flow cytometric method (FCM) for detection of soluble interleukin 2 receptor (sIL-2R) in serum was established. Using this method, results from one to forty samples can be obtained in less than 2 hr as compared with 5 hr in an ELISA. Comparing over 300 sera samples tested by both methods, we found the FCM to be as specific and sensitive as the ELISA, but even more reproducible. Regression analysis of ELISAt on FCMt showed there is a strong relationship between the two assays and they mimic each other over time. We studied the daily serum levels of sIL-2R by FCM in 18 liver allograft recipients: 7 were in the stable group, 6 in the rejection group, and 5 had both rejection and infection. Low or decreasing sIL-2R levels correlated with absence of rejection. In patients with rejection episodes, a typical elevation of sIL-2R was followed by a rapid decrease of sIL-2R after successful response to rejection therapy. Patients with multiple complications displayed elevated sIL-2R levels. In conclusion, because of its rapid turnover time and accuracy, the FCM has the potential to determine the appropriate timing of post-transplant liver biopsies.
Cohen
N
N
Immunogenetics and Transplantation Laboratory, University of California, San Francisco 94143-0508.
Gumbert
M
M
Birnbaum
J
J
Lim
V L
VL
Falco
D
D
Ascher
N
N
Roberts
J
J
Garovoy
M R
MR
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D005434:Flow Cytometry; D006084:Graft Rejection; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology*; D016853:Muromonab-CD3; D015375:Receptors, Interleukin-2 / Q000032:analysis* / Q000378:metabolism; D012995:Solubility
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3; D015375:Receptors, Interleukin-2